What Pfizer / AstraZeneca rerally meant to the M&A landscape

Now watching

Next video starts in : 7 Play

What Pfizer / AstraZeneca rerally meant to the M&A landscape

What Pfizer / AstraZeneca rerally meant to the M&A landscape
Replay video
Up next

Should we expect surprises from Apple's report?

Unlock your personal NFL Now stream by signing in to NFL.com

What Pfizer / AstraZeneca rerally meant to the M&A landscape

by Breakout Videos 2:31 mins

What Pfizer / AstraZeneca rerally meant to the M&A landscape

by Breakout Videos 2:31 mins

As is true in business so it is in life: just because someone really, really wants to be with you doesn’t mean you can play hard to get forever. After six-months of courting AstraZeneca, Pfizer announced that it had pulled its $118 billion offer and had no plans to attempt a hostile acquisition.

More From

Finance

Market Movers

  1. 13:30

    Wall Street's record followup; Apple earnings preview; Chipotle's GMO-free menu

  2. 2:41

    Apple Earnings Preview

  3. 3:13

    Chipotle removes GMO products from menu

  4. 2:51

    Pharmaceutical companies increase drug prices: WSJ Report

  5. 1:52

    Apple jumps ahead of earnings; Applied Materials merger falls apart; Deutsche Bank overhaul plan

  6. 14:30

    Nasdaq set to top record; Apple Watch deliveries; Comcast abandons merger

Market Movers

  1. 13:30

    Wall Street's record followup; Apple earnings preview; Chipotle's GMO-free menu

  2. 2:41

    Apple Earnings Preview

  3. 3:13

    Chipotle removes GMO products from menu

  4. 2:51

    Pharmaceutical companies increase drug prices: WSJ Report

  5. 1:52

    Apple jumps ahead of earnings; Applied Materials merger falls apart; Deutsche Bank overhaul plan

  6. 14:30

    Nasdaq set to top record; Apple Watch deliveries; Comcast abandons merger